TWO-YEAR ADMINISTRATION DATA OF AN ORAL TESTOSTERONE UNDECANOATE (TU) FORMULATION IN HYPOGONADAL MEN

被引：0
|
作者：
Swerdloff, R. [1 ]
Honig, S. [2 ]
Wang, C. [1 ]
Gittelman, M. [3 ]
Sea, B. W. [4 ]
Rohowsky, N. [5 ]
Dudley, R. [1 ]
机构：
[1] Lundquist Inst Harbor UCLA, Los Angeles, CA USA
[2] Yale Sch Med, New Haven, CT USA
[3] UroMedix & South Florida Med Res, Aventura, FL USA
[4] Clarus Therapeut, Northbrook, IL USA
[5] Integrated Data Consultat Serv Inc, Bellrosemanor, NY USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2022年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
3
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [31] Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men
    Jockenhoevel, F.
    Minnemann, T.
    Schubert, M.
    Freude, S.
    Huebler, D.
    Schumann, C.
    Christoph, A.
    Ernst, M.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 160 (05) : 815 - 819
  • [32] PLASMA ANDROGEN LEVELS IN MEN AFTER ORAL-ADMINISTRATION OF TESTOSTERONE OR TESTOSTERONE UNDECANOATE
    NIESCHLAG, E
    MAUSS, J
    COERT, A
    KICOVIC, P
    ACTA ENDOCRINOLOGICA, 1975, 79 (02): : 366 - 374
  • [33] MONITORING TESTOSTERONE (T) LEVELS IN MEN RECEIVING ORAL TESTOSTERONE UNDECANOATE (TU): DEALING WITH POST-COLLECTION CONVERSION OF TU TO T
    Kaminetsky, Jed
    Gittelman, Marc
    Swerdloff, Ronald
    Longstreth, James
    Dudley, Robert
    Danoff, Theodore
    JOURNAL OF UROLOGY, 2019, 201 (04): : E859 - E859
  • [34] EFFECTS OF ORAL TESTOSTERONE UNDECANOATE ON SEMEN PARAMETERS IN HYPOGONADAL MEN: AN INTERIM ANALYSIS OF A PROSPECTIVE PILOT STUDY
    Saffati, G.
    Rendon, D. Orozco
    Kronstedt, S.
    Hinojosa-Gonzalez, D.
    Khera, M.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [35] Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men
    Nieschlag, E
    Büchter, D
    von Eckardstein, S
    Abshagen, K
    Simoni, M
    Behre, HM
    CLINICAL ENDOCRINOLOGY, 1999, 51 (06) : 757 - 763
  • [36] Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
    Narayana, Nandini Shankara
    Ly, Lam P.
    Jayadev, Veena
    Fennell, Carolyn
    Savkovic, Sasha
    Conway, Ann J.
    Handelsman, David J.
    ENDOCRINE CONNECTIONS, 2021, 10 (07) : 758 - 766
  • [37] ANDROGEN REPLACEMENT WITH ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MEN - A DOUBLE-BLIND CONTROLLED-STUDY
    SKAKKEBAEK, NE
    BANCROFT, J
    DAVIDSON, DW
    WARNER, P
    CLINICAL ENDOCRINOLOGY, 1981, 14 (01) : 49 - 61
  • [38] Prostate cancer incidence in 340 hypogonadal men treated with testosterone undecanoate injections (TU) for up to 7 years: Observational data from a registry study
    Haider, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [39] EFFECTS OF ORAL TESTOSTERONE UNDECANOATE ON PLASMA TESTOSTERONE AND CLINICAL SYMPTOMATOLOGY IN HYPOGONADAL MALE PATIENTS
    MIES, R
    KREMPL, S
    ACTA ENDOCRINOLOGICA, 1977, 85 : 119 - 119
  • [40] ERECTILE FUNCTION IN 656 HYPOGONADAL MEN: RESULTS OF LONG TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN COMPARISON WITH CONTROL GROUP
    Haider, Ahmad
    Haider, Karim
    Saad, Farid
    Doros, Gheorghe
    Traish, Abdulmaged
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1007 - E1007
12345